Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

INTRODUCTION: Real-world evidence has demonstrated improved glycemic control and insulin management following introduction of smart insulin pens in a Swedish type 1 diabetes (T1D) population. To understand the implications for healthcare costs and expected health outcomes, this analysis evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jendle, Johan, Ericsson, Åsa, Gundgaard, Jens, Møller, Jonas Bech, Valentine, William J., Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843677/
https://www.ncbi.nlm.nih.gov/pubmed/33306169
http://dx.doi.org/10.1007/s13300-020-00980-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843677/
https://www.ncbi.nlm.nih.gov/pubmed/33306169
http://dx.doi.org/10.1007/s13300-020-00980-1

Ejemplares similares